Wells Fargo & Company Boosts Medtronic (NYSE:MDT) Price Target to $105.00

Medtronic (NYSE:MDT – Free Report) had its price objective lifted by Wells Fargo & Company from $102.00 to $105.00 in a research note issued to investors on Friday, Benzinga reports. They currently have an overweight rating on the medical technology company’s stock. A number of other equities research analysts also recently issued reports on the […]

Related Keywords

Canada ,Michael Marinaro ,Needham Company ,Royal Bank ,Morgan Stanley ,Wells Fargo Company ,Norges Bank ,York Mellon Corp ,Capital Research Global Investors ,Medtronic ,Northern Trust Corp ,Medtronic Company Profile ,Free Report ,Wells Fargo ,Truist Financial ,Get Free Report ,Research Global Investors ,New York Mellon Corp ,Trust Corp ,Cardiovascular Portfolio ,Medtronic Daily ,